Correction to: Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study

被引：0
|
作者：
Emmanuelle Kuhn
Philippe Caron
Brigitte Delemer
Isabelle Raingeard
Hervé Lefebvre
Gérald Raverot
Christine Cortet-Rudelli
Rachel Desailloud
Clementine Geffroy
Robin Henocque
Yves Brault
Thierry Brue
Philippe Chanson
机构：
[1] Centre de Référence des Maladies Rares de l’Hypophyse HYPO,Assistance Publique
[2] Université Paris-Saclay (Université Paris-Sud),Hôpitaux de Paris, Hôpital Bicêtre
[3] Inserm,undefined
[4] Signalisation Hormonale,undefined
[5] Physiopathologie Endocrinienne et Métabolique,undefined
[6] CHU de Toulouse,undefined
[7] Hôpital Larrey,undefined
[8] 24 Chemin de Pouvourville,undefined
[9] TSA 30030,undefined
[10] CHU de Reims—Hôpital Robert Debré,undefined
[11] Avenue du Général Koenig,undefined
[12] CHRU de Montpellier,undefined
[13] Maladies Endocriniennes,undefined
[14] Hopital Lapeyronie,undefined
[15] CHU de Rouen,undefined
[16] Hospices civils de Lyon,undefined
[17] Hôpital Louis Pradel,undefined
[18] CHR Lille,undefined
[19] Hôpital Claude Huriez,undefined
[20] Rue Michel Polonovski,undefined
[21] CHU d’Amiens,undefined
[22] Hôpital Nord,undefined
[23] Place Victor Pauchet,undefined
[24] Pfizer France,undefined
[25] CHU de Marseille,undefined
[26] Hôpital de la Conception,undefined
来源：
Endocrine | 2021年 / 71卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
引用
收藏
页码：265 / 265
相关论文
共 41 条
  • [21] Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: A prospective study in 99 patients
    Colao, Annamaria
    Pivonello, Rosario
    Auriemma, Renata S.
    Briganti, Francesco
    Galdiero, Mariano
    Tortora, Fabio
    Caranci, Ferdinando
    Cirillo, Sossio
    Lombardi, Gaetano
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (06): : 2112 - 2118
  • [22] Remission of acromegaly after treatment withdrawal in patients controlled by cabergoline alone or in combination with octreotide: results from a multicenter study
    A. Casagrande
    M. D. Bronstein
    R. S. Jallad
    J. I. Mota
    A. Tabet
    J. Abucham
    Journal of Endocrinological Investigation, 2017, 40 : 523 - 528
  • [23] Remission of acromegaly after treatment withdrawal in patients controlled by cabergoline alone or in combination with octreotide: results from a multicenter study
    Casagrande, A.
    Bronstein, M. D.
    Jallad, R. S.
    Mota, J. I.
    Tabet, A.
    Abucham, J.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2017, 40 (05): : 523 - 528
  • [24] Efficacy and safety of high-dose long-acting repeatable octreotide as monotherapy or in combination with pegvisomant or cabergoline in patients with acromegaly not adequately controlled by conventional regimens: results of an open-label, multicentre study
    Colao, Annamaria
    Zgliczynski, Wojciech
    Komorowski, Jan
    Kos-Kudla, Beata
    Tabarin, Antoine
    Kerlan, Veronique
    Minuto, Francesco M.
    Scaroni, Carla
    Bolanowski, Marek
    ENDOKRYNOLOGIA POLSKA, 2019, 70 (04) : 305 - 312
  • [25] Changes in Urinary Microalbumin Levels after Correction of Hyperuricemia in Patients with Gout: An Observational Cohort Study
    Vaidya, Binit
    Pudasaini, Kalpana
    Nakarmi, Shweta
    INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2020, 2020
  • [26] Prolonged preoperative treatment of acromegaly with Somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1–3): a retrospective cohort study conducted at a single center
    Lian Duan
    Huijuan Zhu
    Bing Xing
    Feng Gu
    BMC Endocrine Disorders, 17
  • [27] Low frequency of cardniac arrhythmias and lack of structural heart disease in medically-na⟨ve acromegaly patients: a prospective study at baseline and after 1 year of somatostatin analogs treatment
    Warszawski, Leila
    Kasuki, Leandro
    Sa, Rodrigo
    dos Santos Silva, Cintia Marques
    Volschan, Isabela
    Gottlieb, Ilan
    Pedrosa, Roberto Coury
    Gadelha, Monica R.
    PITUITARY, 2016, 19 (06) : 582 - 589
  • [28] Low frequency of cardniac arrhythmias and lack of structural heart disease in medically-naïve acromegaly patients: a prospective study at baseline and after 1 year of somatostatin analogs treatment
    Leila Warszawski
    Leandro Kasuki
    Rodrigo Sá
    Cintia Marques dos Santos Silva
    Isabela Volschan
    Ilan Gottlieb
    Roberto Coury Pedrosa
    Mônica R. Gadelha
    Pituitary, 2016, 19 : 582 - 589
  • [29] Survival of amyotrophic lateral sclerosis patients after admission to the intensive care unit for acute respiratory failure: an observational cohort study
    Mayaux, Julien
    Lambert, Jerome
    Morelot-Panzini, Capucine
    Gonzalez-Bermejo, Jesus
    Delemazure, Julie
    Llontop, Claudia
    Bruneteau, Gaelle
    Salachas, Francois
    Dres, Martin
    Demoule, Alexandre
    Similowski, Thomas
    JOURNAL OF CRITICAL CARE, 2019, 50 : 54 - 58
  • [30] Prolonged preoperative treatment of acromegaly with Somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1-3): a retrospective cohort study conducted at a single center
    Duan, Lian
    Zhu, Huijuan
    Xing, Bing
    Gu, Feng
    BMC ENDOCRINE DISORDERS, 2017, 17
12345